QQE WART REMOVER - Guangzhou Huixue Biotechnology Co., Ltd.
- Manufacturer
- Guangzhou Huixue Biotechnology Co., Ltd.
- Effective date
- 2026-05-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-06-03 18:03:35
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid 40%
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
if swallowed, seek medical attention or contact a Poison Control Center (1-800-222-1222) immediately.
OTC - PURPOSE SECTION
Uses For the removal of warts, including plantar warts, flat warts, common warts, corns, and calluses.
WARNINGS SECTION
Warnings For external use only. Flammable Keep away from fire and flame. Keep out of reach of children. Avoid contact with eyes, in case of contact, flush eyes with plenty of cool water. Do not swallow
INACTIVE INGREDIENT SECTION
Water, Borneol, Glycerin, Polyethylene Glycol, Bisabolol, Allantoin, Lonicera Japonica (Honeysuckle) Flower Extract, Sophora Augustifolia Root Extract, Hyaluronic Acid, Aloe Vera Extract,Cnidium Monnieri Extract, Gentiana Scabra Root Extract, Portulaca Oleracea Extract, Zingiber Officinale (Ginger) Root Extract.
DOSAGE & ADMINISTRATION SECTION
1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional), 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry 3. Repeat this process 2-3 times daily until the skin looks smooth. 4. More severe may require more time.Patience and perseverance are required during its use. The longest continuous use period is no more than 12 weeks.
OTC - DO NOT USE SECTION
On broken skin or the area around the eyes. On irritated skin or on any area that is infected or reddened.Do not use If you are allergic to any ingredient in this product. .On moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes. • If you have diabetes or poor blood circulation. If you are pregnant or breastfeeding ness rec y hare practitioner.
OTC - STOP USE SECTION
Discontinue use and consult a doctor if: . You become pregnant or are trying to become pregnant while using this product. Irritation or redness occurs, worsens, or does not improve with continued use.
OTC - WHEN USING SECTION
1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth.
INDICATIONS & USAGE SECTION
plantar warts, flat warts, common warts, corns, and calluses.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- QQE WART REMOVER
- Salicylic Acid 40%
- GLYCERIN
- WATER
- ALLANTOIN
- BISABOLOL
- HYALURONIC ACID
- SALICYLIC ACID, CHLOROACETATE
- BORNEOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 87204-177 | 87204-177-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| ALLANTOIN | 344S277G0Z | IACT |
| BISABOLOL | 24WE03BX2T | IACT |
| HYALURONIC ACID | S270N0TRQY | IACT |
| SALICYLIC ACID, CHLOROACETATE | LG4R4S2VYN | ACTIB |
| BORNEOL | M89NIB437X | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QQE WART REMOVER | SALICYLIC ACID 40% | Guangzhou Huixue Biotechnology Co., Ltd. | 5279f8c8-09ae-8483-e063-6394a90a00e6 | 2026-05-23 | Warnings | 87204-177-01 87204-177 87204017701 5279f8c8-09af-8483-e063-6394a90a00e6 5279f8c8-09ae-8483-e063-6394a90a00e6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
